E

EuBiologics Co Ltd
KOSDAQ:206650

Watchlist Manager
EuBiologics Co Ltd
KOSDAQ:206650
Watchlist
Price: 11 940 KRW 0.59%
Market Cap: 436.2B KRW
Have any thoughts about
EuBiologics Co Ltd?
Write Note

EuBiologics Co Ltd
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

EuBiologics Co Ltd
Total Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
E
EuBiologics Co Ltd
KOSDAQ:206650
Total Current Assets
â‚©41.8B
CAGR 3-Years
-12%
CAGR 5-Years
18%
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Total Current Assets
â‚©5T
CAGR 3-Years
20%
CAGR 5-Years
23%
CAGR 10-Years
20%
SK Bioscience Co Ltd
KRX:302440
Total Current Assets
â‚©1.4T
CAGR 3-Years
61%
CAGR 5-Years
50%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Total Current Assets
â‚©552.6B
CAGR 3-Years
-3%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Total Current Assets
â‚©337.7B
CAGR 3-Years
31%
CAGR 5-Years
28%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Total Current Assets
â‚©167.4B
CAGR 3-Years
-9%
CAGR 5-Years
25%
CAGR 10-Years
N/A
No Stocks Found

EuBiologics Co Ltd
Glance View

Market Cap
435.3B KRW
Industry
Biotechnology

EuBiologics Co., Ltd. engages in the research, development, and manufacture of biopharmaceutical products. The company is headquartered in Seoul, Seoul and currently employs 323 full-time employees. The company went IPO on 2017-01-24. The firm operates its business through two segments. The Vaccine segment manufactures and sells oral cholera vaccines. The Contract Research and Manufacturing Organization (CRMO) segment contracts, researches and manufactures biopharmaceuticals.

Intrinsic Value
17 631.48 KRW
Undervaluation 32%
Intrinsic Value
Price
E

See Also

What is EuBiologics Co Ltd's Total Current Assets?
Total Current Assets
41.8B KRW

Based on the financial report for Sep 30, 2024, EuBiologics Co Ltd's Total Current Assets amounts to 41.8B KRW.

What is EuBiologics Co Ltd's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
18%

Over the last year, the Total Current Assets growth was 21%. The average annual Total Current Assets growth rates for EuBiologics Co Ltd have been -12% over the past three years , 18% over the past five years .

Back to Top